Viewing Study NCT01495351


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2025-12-25 @ 9:44 PM
Study NCT ID: NCT01495351
Status: COMPLETED
Last Update Posted: 2017-09-25
First Post: 2011-11-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma
Sponsor: AHS Cancer Control Alberta
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module